SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Fuelled by strong revenue performance and AI PC demand, Intel is trending as community members discuss whether this rally is sustainable. While some are taking profits, others are holding, betting on future partnerships and the company's role in the AI landscape. Traders are closely watching how option premiums will be affected.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a significant surge potentially fueled by news of insider buying and a milestone payment from Merck related to their Alzheimer's program. The community is actively discussing the low float and potential for a short squeeze, with some speculating about a potential run to double digits. However, some traders caution about potential dilution.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses its potential, particularly highlighting its data provision partnership with Kalshi. Bullish sentiment is fueled by comparisons to other crypto projects, with some anticipating new all-time highs. Community members are also speculating on potential integrations with other platforms.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

DECK is trending as investors react to recent earnings and guidance, with community chatter focused on whether the stock's dip is an overreaction or a sign of deeper issues. Discussions also include concerns about slowing sales growth and the potential impacts of tariffs, alongside debates about the brand's long-term value. Technical analysis and swing trade opportunities are being weighed amid the mixed sentiment.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending as investors discuss its potential role in the AI infrastructure buildout, particularly following news of a partnership with Palantir; the community is focused on the company's AI strategy and its potential impact on future growth, while acknowledging its debt load. Some believe LUMN's extensive fiber network positions it to benefit significantly from the increasing demand for data connectivity, drawing comparisons to other AI-related stocks.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending due to a mix of factors, including analyst price target adjustments and high trading volume. While some community members are eyeing potential shorting opportunities around resistance levels, others are celebrating gains and anticipating further upward movement, possibly fueled by tariff relief. Discussions also involve the company's EV strategy and the broader automotive market dynamics.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending due to a potential short squeeze, with community members highlighting a high cost to borrow, low float, and insider buying from Vlad Galkin; some believe Galkin's accumulation of shares could trigger a significant price increase, potentially burning short sellers. The community is closely monitoring share availability and CTB rates, suggesting a possible 'float trap' scenario. Some users speculate Galkin's investments are tied to synergy with his distribution company, HUBX.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions around Trump's policies, including trade relations with Canada and the construction of a ballroom at the White House. Community talking points revolve around perceived political biases, potential short squeezes, and the stock's overall performance. Some users are expressing concerns about corruption and economic policies.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp ($NEM) is trending as investors discuss its recent Q3 earnings beat and subsequent stock slip, with some citing a drop in gold production. Community sentiment is mixed, with debates around company management, market manipulation, and future potential amidst fluctuating gold prices. Discussions also include Goldman Sachs increasing the stock's price target.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

Genenta (GNTA) is trending after announcing a strategic partnership, leading to a massive pre-market surge that caught the attention of day traders and momentum-focused investors. Community discussions revolve around the sustainability of the rally, potential short squeeze dynamics, and the significance of the partnership for the company's long-term prospects. The stock's volatile price action and history of similar pumps are also key talking points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Petrochemicals company <a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/supreme-petrochem-share-price/SP/" target="_blank" rel="noopener">Supreme Petrochem Ltd</a> on Friday (October 24) reported a net profit of ₹148 crore for Q2 FY26, up 63% year-on-year from ₹91 crore. Revenue for the quarter declined 55% to ₹1,117 crore compared with ₹2,519 crore in the same period last year. 
The company’s EBITDA stood at ₹78.7 crore, down 59.6% from ₹194 crore in Q2 FY25. EBITDA margin was at 7%, slightly lower than 7.7% in the year-ago period. 
Supreme Petrochem has declared an interim dividend of ₹2.50 per equity share, equivalent to 2.125% of its paid-up equity capital, for the financial year 2025-26. 
 
Also Read: <a href="https://www.cnbctv18.com/market/earnings/supreme-petrochem-targets-13-14-volume-growth-in-fy26-19593799.htm">Supreme Petrochem targets 13-14% volume growth in FY26</a> 
 
The company’s paid-up capital consists of 18,804,134 equity shares of ₹2 each, entailing a total outgo of ₹47.01 crore. The record date for determining the eligibility of shareholders to receive the interim dividend has been fixed as Friday, October 31, 2025. 
 
In July this year, Supreme Petrochem said it is aiming for a 12% growth in volumes in FY26, even as the company posted muted numbers for the June quarter. "We hope to achieve close to 12% volume growth this year," said Rakesh Nayyar, Executive Director of Supreme Petrochem, in an interview with CNBC-TV18. 
The company's volumes in the first quarter remained flat compared to last year, with only a marginal uptick of 0.5%. Demand from the domestic market was subdued, largely due to lower lifting by OEMs amid unseasonal rains that impacted sales of cooling appliances like refrigerators and air conditioners. “The growth was muted this year,” Nayyar noted, adding that even the non-OEM segment saw tepid demand. 
 
Also Read: <a href="https://www.cnbctv18.com/market/stocks/supreme-petrochem-share-price-commissions-first-abs-line-70000-tpa-capacity-maharashtra-19690125.htm">Supreme Petrochem starts production in 70,000 TPA Maharashtra plant</a> 
 
On the pricing front, a sharp correction in styrene monomer—its key raw material—also weighed on the topline. Between March and April, prices of styrene fell, which in turn led to lower selling prices for the company. 
 
 
 
Shares of Supreme Petrochem Ltd ended at ₹812.00, up by ₹9.40, or 1.17%, on the BSE.

Supreme Petrochem reports ₹148 crore profit in Q2, revenue falls 55%; dividend announced

Supreme Petrochem has declared an interim dividend of ₹2.50 per equity share, equivalent to 2.125% of its paid-up equity capital, for the financial year 2025-26. Shares of Supreme Petrochem Ltd ended at ₹812.00, up by ₹9.40, or 1.17%, on the BSE.

Equity

India’s foreign exchange reserves rose by $4.496 billion to reach $702.28 billion for the week ended October 17, data released by the Reserve Bank of India (RBI) showed on Friday. 
 
In the previous week, reserves had increased by $2.176 billion to $697.784 billion. 
 
Foreign currency assets (FCAs), the biggest component of the reserves, however, declined by $1.692 billion to $570.411 billion during the week. FCAs include the effects of appreciation or depreciation of non-US currencies such as the euro, pound, and yen held in the reserves, the RBI noted. 
 
The value of India’s gold reserves surged by $6.181 billion to $108.546 billion, marking a significant increase and reflecting both price movements in the global bullion market and possible valuation gains due to dollar weakness. Gold reserves have played a larger role in recent months as global investors turn to the precious metal amid geopolitical uncertainty and inflationary pressures. 
 
Special Drawing Rights (SDRs) with the International Monetary Fund (IMF) also increased by $38 million to $18.722 billion, while India’s reserve position with the IMF fell by $30 million to $4.602 billion. 
 
The steady rise in reserves underscores the RBI’s proactive intervention to stabilise the rupee and manage external shocks amid a strong dollar and volatile crude prices. The recent uptick in gold valuation has also contributed to the headline increase. 
 
India’s reserves have hovered near record highs, strengthening macroeconomic stability and providing ample cover for imports and external debt obligations.

India's forex reserves rise by $4.5 billion to $702.28 billion for week ended Oct 17

In the previous week, reserves had increased by $2.176 billion to $697.784 billion.

RailTel Corporation of India Ltd. has had a work order worth ₹209.78 crore cancelled by Bihar Education Project Council (BEPC). 
The order was originally issued under the State Project Director, BEPC, for execution of the ‘Education Quality Enhancement Project’ under the PM‑SHRI initiative in Bihar, with an aim to strengthen digital and educational infrastructure. 
According to RailTel’s disclosure under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the cancellation was effected due to unavoidable reasons. 
RailTel now faces the task of re-evaluating its project pipeline and recognisin alternative opportunities to mitigate the impact of this cancellation.

RailTel’s ₹209.78 crore order cancelled by Bihar Education Project Council

According to RailTel’s disclosure under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the cancellation was effected due to unavoidable reasons.

Leading pure-play credit card issuer <a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/sbi-cards-payment-services-share-price/SCP02/" target="_blank" rel="noopener">SBI Cards and Payments Services Ltd</a> on Friday (October 24) reported a 10% year-on-year increase in net profit for Q2 FY26, reaching ₹445 crore, up from ₹404 crore in the same period last year. The company’s revenue grew 12.2% YoY to ₹4,960 crore, compared with ₹4,421 crore in Q2 FY25. 
 
Asset quality showed improvement, with gross non-performing assets (GNPA) declining to 2.85% from 3.07% sequentially. Net NPA also fell to 1.29% from 1.42% in the previous quarter. 
 
SBI Cards' return on average assets (ROAA) stood at 2.6% compared with 2.7% in Q2 FY25, and return on average equity (ROAE) at 12.1% versus 12.5% in the same period last year. The company maintained a strong capital adequacy ratio (CRAR) of 22.5%, with Tier 1 capital at 17.5%. 
 
 
Also Read: <a href="https://www.cnbctv18.com/photos/personal-finance/sbi-credit-card-changes-fees-new-charges-november-1-rules-19724188.htm">Full list of SBI Card fees and charges changing from November 1</a> 
 
 
 
 
The company’s cards-in-force grew 10% YoY to 2.15 crore in Q2 FY26 from 1.96 crore in Q2 FY25. New account additions rose to 936,000 in the quarter versus 904,000 a year ago. Cardholder spends surged 31% YoY to ₹1,07,063 crore, while receivables increased 8% YoY to ₹59,845 crore. 
 
As per RBI data available till August 2025, SBI Cards held a market share of 19.0% for cards-in-force (up from 18.5%) and 17.0% for spends (up from 15.7%), ranking #2 in cards-in-force and #3 in spends in the industry. 
 
Total income for the quarter rose 13% YoY to ₹5,136 crore from ₹4,556 crore, driven by interest income of ₹2,490 crore (up 9% YoY) and fees and commission income of ₹2,471 crore (up 16% YoY). Finance costs declined 4% to ₹760 crore due to lower borrowing costs. 
 
Also Read: <a href="https://www.cnbctv18.com/market/stocks/sbi-card-share-price-q1fy26-results-net-profit-drops-nii-total-income-bad-debts-impairments-19643735.htm">SBI Card Q1 Results | Net profit drops 6% amid rising bad debts, impairments; NII up</a> 
 
 
 
 
 
Total operating expenses increased 24% to ₹2,484 crore from ₹2,011 crore in Q2 FY25. Earnings before credit costs (EBCC) rose 8% YoY to ₹1,892 crore, while impairment losses and bad debt expenses increased 7% to ₹1,293 crore. 
 
On the balance sheet front, as of September 30, 2025, total assets stood at ₹69,862 crore compared with ₹65,546 crore as of March 31, 2025. Total advances (net of provisions) were ₹57,856 crore, up from ₹53,935 crore, and net worth reached ₹14,861 crore, against ₹13,853 crore at the end of the previous fiscal year. 
 
Asset quality improved, with gross non-performing assets (GNPA) at 2.85% of gross advances, down from 3.27% a year ago. Net NPA stood at 1.29%, slightly higher than 1.19% in Q2 FY25. The company maintained a robust CRAR of 22.5%, exceeding the RBI’s minimum requirement of 15%, compared with 22.1% as of September 30, 2024. 
 
Also Read: <a href="https://www.cnbctv18.com/personal-finance/sbi-card-announces-transaction-fee-changes-november-reward-points-19700819.htm">SBI Card announces transaction fee changes from November</a> 
 
 
 
 
 
Shares of SBI Cards and Payment Services Ltd ended at ₹936.45, up by ₹7.85, or 0.85%, on the BSE.

SBI Card Q2 net profit and revenue climb amid strong cardholder growth

SBI Cards' return on average assets (ROAA) stood at 2.6% compared with 2.7% in Q2 FY25, and return on average equity (ROAE) at 12.1% versus 12.5% in the same period last year. Shares of SBI Cards and Payment Services Ltd ended at ₹936.45, up by ₹7.85, or 0.85%, on the BSE.

Realty firm <a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/puravankara-share-price/PP01/" target="_blank" rel="noopener">Puravankara Ltd</a> on Friday (October 24) said its wholly-owned unlisted subsidiary, Starworth Infrastructure &amp; Construction Ltd, has received a Letter of Award (LOA) from SBR Builders for the construction of core &amp; shell with finishes works for the proposed residential project, "SBR Global Queen’s Ville." 
 
The order, valued at ₹211.53 crore, is a domestic residential building project. The execution timeline will be as specified in the Letter of Award. Puravankara clarified that neither the promoter nor the promoter group nor the group companies have any interest in SBR Builders, and the order does not qualify as a related party transaction. 
 
 
 
 
 
 
 
Last week, Puravankara said it plans to launch around 15 million square feet of projects over the next 12 to 15 months, said Managing Director Ashish Puravankara. The company expects to achieve about 65% of this target by March 2026. 
 
Also Read: <a href="https://www.cnbctv18.com/market/stocks/puravankara-share-price-q4fy25-net-loss-revenue-ebitda-margins-fy25-pre-sales-cross-rs-5000-crore-19613405.htm">Puravankara net loss widens to ₹88 cr in Q4 as revenue falls 41%; FY25 pre-sales cross ₹5,000 crore</a> 
 
“In terms of the new launches that we've planned, it’s about 15 million square feet over the next 12 to 15 months,” Puravankara said. “About 65% of that we should be able to achieve by March itself.” He added that the company expects healthy contributions from these new projects, given its record of selling 70-80% of launched phases within the first two quarters. 
 
For the second quarter of the financial year 2025-26 (Q2 FY26), the company achieved ₹1,322 crore in pre-sales, translating to 1.5 million square feet - about 4% higher year-on-year. Customer collections stood at ₹1,047 crore. For the half-year, Puravankara recorded pre-sales of ₹2,445 crore and customer collections of ₹1,906 crore. 
 
"All these pre-sales have come from ongoing sustenance projects. We still have to see the benefit from our new launches slated for quarter three and quarter four,” he said. 
 
Shares of Puravankara Ltd ended at ₹281.00, up by ₹0.65, or 0.23%, on the BSE. 
 
 
 
Also Read: <a href="https://www.cnbctv18.com/market/puravankara-q2-update-shares-gain-on-pre-sales-collections-and-average-selling-price-growth-19709594.htm">Puravankara Q2 Update: Shares gain on pre-sales, collections, and average selling price growth</a>

Puravankara subsidiary bags ₹212 crore order for SBR Global Queen's Ville residential project

The order, valued at ₹211.53 crore, is a domestic residential building project. The execution timeline will be as specified in the Letter of Award. Shares of Puravankara Ltd ended at ₹281.00, up by ₹0.65, or 0.23%, on the BSE.

An Apple fee of up to 30% in India will over time stifle revenues for Match, the owner of dating app Tinder, it said in its submission to the Indian antitrust body, adding that hefty fines were needed to protect its business. 
 
Tinder is one of the biggest players in the Indian dating apps market, which will be worth an estimated $1.42 billion by 2030, according to advisory firm MarketNtel. 
 
Since 2022, Match has been locked in an antitrust battle with Apple at the Competition Commission of India, where investigators last year issued a report saying the US smartphone company had engaged in ”abusive conduct” on the apps market of its iPhone Operating System, iOS. 
 
Apple has denied wrongdoing and said it is a small player in India where phones mostly use Google’s Android system. It did not respond to a request on Friday for comment. 
 
Match and the CCI also did not respond to Reuters queries. 
 
In a response dated October 13 to the CCI investigators’ findings, which Reuters is the first to report on, Match urged the watchdog to issue final directives asking Apple to discontinue its anti-competitive practices. 
 
"Apple’s policies adversely affect the return on capital and revenue streams of Match’s portfolio brands,” Match said in its submissions, reviewed by Reuters. 
 
"In the long term, the constraints and excessive fee imposed by Apple will stifle the growth and scalability of Match’s portfolio brands,” it added, without quantifying the impact. 
 
As Apple faces antitrust scrutiny across the world, on Thursday, a London tribunal ruled it abused its dominant position by charging app developers unfair commissions. 
 
'TINDER AND UBER BOTH OFFER MATCHMAKING’ 
 
Apple’s smartphone base has become four times larger in the last five years in India. 
 
Its iOS powered an estimated 4.5% of 735 million smartphones in India as of mid-2025, with the rest using Android, Counterpoint Research says. 
 
The CCI has powers to fine Apple up to 10% of its global average turnover for the last three financial years. 
 
Such a fine based on global turnover, not Indian, could "act as a significant deterrent against recidivism,” Match said in its submission. 
 
The CCI investigation team found last year that Apple was not permitting any third-party payment processor to provide the services for in-app purchases, where the fee could be up to 30%. 
 
Match’s latest submission cited discriminatory treatment, saying Uber’s ride-hailing app was classified by Apple as providing physical goods, and was charged lower commission than Tinder, which is treated as providing digital services. 
 
"Tinder and Uber both offer matchmaking services in essence,” Match said in its filing. 
 
In April, the EU watchdog said Apple must remove restrictions that prevent app developers from steering users to cheaper deals outside the App Store, and fined the company 500 million euros ($583 million). 
 
Apple in June changed its App Store rules to comply with the EU order.

Tinder owner Match says Apple fee will stifle growth in India

Since 2022, Match has been locked in an antitrust battle with Apple at the Competition Commission of India, where investigators last year issued a report saying the US smartphone company had engaged in ”abusive conduct” on the apps market of its iPhone Operating System, iOS.

India’s markets regulator has barred 13 individuals from the securities market, after finding them guilty of front running trades placed by three trusts, according to a statement from late Thursday. 
 
Front running is trading of stocks or other assets based on insider knowledge of a future transaction. 
 
The Securities and Exchange Board of India conducted an investigation related to alleged placing of orders of three entities, namely, Bharat Kanaiyalal Sheth Family, Ravi Kanaiyalal Sheth Family and Arjun Discretionary Trust. 
 
The probe ran for the period from January 1, 2021 to October 31, 2022. 
 
SEBI has also imposed on the 13 individuals penalties ranging between ₹5 lakh and ₹15 lakh for making illegal gains due to front running the trades of the three trusts. 
 
The individuals traded in the shares before they were bought or sold by the . trusts, the SEBI order showed. 
 
Also Read: <a href="https://www.cnbctv18.com/market/nifty-posts-fourth-straight-weekly-gain-in-2025-all-eyes-on-us-cpi-data-19725528.htm">Nifty posts fourth straight weekly gain in 2025; All eyes on US CPI data</a>

SEBI bars 13 individuals from securities market for front running

Front running is trading of stocks or other assets based on insider knowledge of a future transaction.

The rollout of GST 2.0 is reshaping India’s leisure travel landscape, with affordable stays and experience-focused trips seeing growth, according to data from Thrillophilia, an AI-driven travel and experiences platform. Bookings for accommodations priced between ₹2,000–₹6,000 per night rose 22% year-on-year, now accounting for 48% of all reservations. 
 
Short breaks and weekend getaways are driving this shift. 
 
Two- to three-night trips make up 58% of all stays, up six percentage points from last year, while the average trip duration stands at 2.6 nights. The average booking window has reduced to 21 days, indicating that travellers are planning trips earlier but opting for shorter, more frequent holidays. 
 
Analysts attribute this trend to the combined effect of GST-driven cost savings and the residual festive travel momentum. 
 
“With travel feeling more affordable, people are more open to taking an extra trip or upgrading their stay,” said Abhishek Daga, Co-Founder of Thrillophilia. 
 
Spending patterns also show a shift toward experiences over premium accommodations. The use of air miles and upgrade vouchers increased by 21%, while premium-cabin bookings declined by 2.8 percentage points compared with last year. 
 
Activities such as trekking, local sightseeing, and cultural experiences recorded year-on-year growth of 27%, 24%, and 22%, respectively, with the average activity spend at ₹3,600. 
 
Regionally, Jaipur saw a 26% increase in mid-range stays, Lucknow led family short-break bookings, and Bhopal recorded the highest weekend occupancy at 81%. Hyderabad reported the longest advance planning, while Bhubaneswar led growth in activity-focused trips, and Panaji showed the highest proportion of boutique and homestay bookings. 
 
Across India, domestic trip spending ranges between ₹25,000–₹45,000, while short-haul international holidays average ₹60,000–₹95,000. Travellers are redistributing budgets toward experiences rather than cutting overall spending, signalling a shift toward “smart luxury” travel. 
 
Thrillophilia’s data, based on partnerships with over 5,000 providers across 200 destinations, highlights the growing preference for affordable, experience-driven leisure travel in India.

GST 2.0 boosts affordable leisure spending by 22% this festive season: Report

The rollout of GST 2.0 has driven a 22% year-on-year increase in mid-range leisure spending in India, with consumers opting for shorter, experience-focused getaways. Post-festive trends indicate a shift toward value-driven bookings and smarter allocation of travel budgets.

<a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/indian-oil-corporation-share-price/IOC/" target="_blank" rel="noopener">Indian Oil Corporation Ltd</a> (IOCL) has secured significant relief in an ongoing income-tax dispute for Assessment Year 2016-17. 
 
The Commissioner of Income-tax (Appeals) has partly allowed the company’s appeal, granting relief of ₹1,102.91 crore against the contested tax and interest demand of ₹1,194.07 crore. 
 
IOCL said the balance disputed amount of ₹91.16 crore will now be taken up before the Income-tax Appellate Tribunal. 
 
The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, noting that the case involved multiple disallowances raised during assessment. 
 
The relief is expected to ease a portion of IOC’s contingent liabilities at a time when the sector faces volatile crude prices and refining margins.

Indian Oil gets ₹1,103 crore relief in AY 2016-17 tax dispute

Indian Oil wins major relief in ₹1,194 crore tax dispute for AY16-17 as CIT(A) partly allows appeal; balance ₹91 crore to be contested.

Hyderabad-based drug major <a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/dr-reddys-laboratories-share-price/DRL/" target="_blank" rel="noopener">Dr Reddy’s Laboratories Ltd</a> on Friday (October 24) reported a net profit of ₹1,347 crore for the September quarter (Q2 FY26), up 7.3% year-on-year from ₹1,256 crore, though slightly below the CNBC-TV18 poll estimate of ₹1,403.7 crore. 
 
The company’s revenue increased 9.8% YoY to ₹8,828 crore, compared with ₹8,038 crore in the same period last year, surpassing the poll estimate of ₹8,595.4 crore. 
 
Operating performance showed a mixed trend, with EBITDA at ₹2,010 crore, down 3.2% YoY from ₹2,076.8 crore and below the poll estimate of ₹2,208.5 crore. EBITDA margin stood at 22.8%, compared with 25.8% YoY and 25.7% expected by analysts. 
 
For H1 FY26, consolidated revenues were ₹17,350 crore, reflecting an 11% YoY growth. Growth was broad-based across key markets, except North America Generics, which faced higher price erosion in select products and lower lenalidomide sales. The acquired Consumer Healthcare portfolio in Nicotine Replacement Therapy (NRT) contributed positively to overall performance. 
 
Also Read: <a href="https://www.cnbctv18.com/market/dr-reddy-laboratories-share-usfda-establishment-inspection-report-voluntary-action-indicated-andhra-facility-19723070.htm">Dr Reddy's gets USFDA's Establishment Inspection Report for Andhra facility</a> 
 
Global Generics (GGJ) posted Q2 FY26 revenues of ₹8,500 crore, up 10% YoY and 4% QoQ, with H1 FY26 revenues at ₹15,410 crore, up 10% YoY. North America revenues declined to ₹3,240 crore in Q2 FY26, down 13% YoY and 5% QoQ, with H1 FY26 revenues at ₹6,650 crore, down 12% YoY. The decline was mainly due to price erosion in key products, including Lenalidomide, partially offset by favourable forex and new product launches. 
 
During the quarter, the company launched seven new products and filed five new ANDAs with the USFDA, taking the total filings for H1 FY26 to six. As of September 30, 2025, 75 filings were pending approval, including 73 ANDAs (45 Paragraph IV and 22 "First to File") and two NDAs under Section 505(b)(2). 
 
Europe reported Q2 FY26 revenues of ₹1,380 crore, a 138% YoY and 8% QoQ increase, mainly driven by the NRT portfolio. Excluding NRT, growth was 17% YoY and 12% QoQ. H1 FY26 revenues reached ₹2,650 crore, up 140% YoY. Germany contributed ₹400 crore in Q2 (+23% YoY, +26% QoQ), the UK ₹160 crore (-4% YoY, -10% QoQ), and the rest of Europe ₹120 crore (+35% YoY, +6% QoQ). During the quarter, eight new products were launched. 
 
Also Read: <a href="https://www.cnbctv18.com/market/earnings/dr-reddys-laboratories-share-price-q1-revenue-profit-ebitda-margin-semaglutide-sales-revlimid-19641912.htm">Dr Reddy's Laboratories Q1 | Revenue jumps over 11% to ₹8,545 crore but margin contracts</a> 
 
India revenues reached ₹1,580 crore in Q2 FY26, up 13% YoY and 7% QoQ, with H1 FY26 revenues at ₹3,050 crore (+12% YoY). Growth was driven by price increases, new launches, and higher volumes. The company launched 11 new brands in Q2, taking the H1 total to 16. 
 
Emerging Markets contributed ₹1,650 crore in Q2 FY26 (+14% YoY, +18% QoQ), with H1 revenues at ₹3,060 crore (+16% YoY). Russia grew 28% YoY to ₹870 crore, CIS and Romania ₹230 crore (+9% YoY), and the Rest of the World ₹550 crore (-2% YoY, +9% QoQ). Q2 FY26 saw 24 new product launches across these markets, totalling 50 in H1 FY26. 
 
Pharmaceutical Services and Active Ingredients (PSAI) posted Q2 FY26 revenues of ₹940 crore (+12% YoY, +16% QoQ) and H1 revenues of ₹1,760 crore (+10% YoY), driven by higher API sales, new product launches, and favourable forex. The company filed 37 DMFs in the quarter, taking the H1 total to 49. 
 
Impairments stood at ₹70 crore, including a one-time ₹50 crore charge related to property, plant, and equipment at the Middleburgh facility. Other operating income was ₹270 crore, and net finance income was ₹80 crore for Q2 FY26. 
 
Also Read: <a href="https://www.cnbctv18.com/market/dr-reddys-shares-bachupally-facility-gets-5-observations-us-fda-inspection-ws-l-19673455.htm">Dr Reddy’s Bachupally facility gets 5 observations from US FDA inspection</a> 
 
As of 30th September 2025, Dr Reddy’s Laboratories reported an operating working capital of ₹13,330 crore. The company’s capital expenditure for Q2 FY26 was approximately ₹510 crore, while free cash flow stood at ₹580 crore after accounting for acquisition-related payouts. 
 
Dr Reddy’s had a net cash surplus of ₹2,750 crore and a net debt-to-equity ratio of -0.08 as of the same date. The company’s annualised return on capital employed (RoCE) for Q2 FY26 was 21.9%. 
 
Shares of Dr Reddy's Laboratories Ltd ended at ₹1,282.70, up by ₹3.30, or 0.26%, on the BSE.

Dr Reddy’s Q2 Results | Net profit up 7%, revenue climbs 10% to ₹8,828 crore; beats estimates

Global Generics (GGJ) posted Q2 FY26 revenues of ₹8,500 crore, up 10% YoY and 4% QoQ, with H1 FY26 revenues at ₹15,410 crore, up 10% YoY. North America revenues declined to ₹3,240 crore in Q2 FY26, down 13% YoY and 5% QoQ, with H1 FY26 revenues at ₹6,650 crore, down 12% YoY. Shares of Dr Reddy's Laboratories Ltd ended at ₹1,282.70, up by ₹3.30, or 0.26%, on the BSE.